nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—ABCC10—Cyclosporine—focal segmental glomerulosclerosis	0.685	0.947	CbGbCtD
Cytarabine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0382	0.0529	CbGbCtD
Cytarabine—SLC22A2—nephron—focal segmental glomerulosclerosis	0.0196	0.161	CbGeAlD
Cytarabine—POLB—nephron tubule—focal segmental glomerulosclerosis	0.0108	0.0888	CbGeAlD
Cytarabine—POLB—cortex of kidney—focal segmental glomerulosclerosis	0.00923	0.076	CbGeAlD
Cytarabine—DCTD—nephron tubule—focal segmental glomerulosclerosis	0.00869	0.0716	CbGeAlD
Cytarabine—POLB—Removal of DNA patch containing abasic residue—PCNA—focal segmental glomerulosclerosis	0.00829	0.0544	CbGpPWpGaD
Cytarabine—DCTD—kidney—focal segmental glomerulosclerosis	0.00764	0.0629	CbGeAlD
Cytarabine—POLB—Base Excision Repair—PCNA—focal segmental glomerulosclerosis	0.00758	0.0498	CbGpPWpGaD
Cytarabine—DCTD—cortex of kidney—focal segmental glomerulosclerosis	0.00744	0.0613	CbGeAlD
Cytarabine—NT5E—nephron tubule—focal segmental glomerulosclerosis	0.00672	0.0554	CbGeAlD
Cytarabine—NT5E—kidney—focal segmental glomerulosclerosis	0.00591	0.0487	CbGeAlD
Cytarabine—NT5E—cortex of kidney—focal segmental glomerulosclerosis	0.00575	0.0474	CbGeAlD
Cytarabine—POLE—cortex of kidney—focal segmental glomerulosclerosis	0.00564	0.0464	CbGeAlD
Cytarabine—POLD1—Mismatch repair—PCNA—focal segmental glomerulosclerosis	0.00528	0.0347	CbGpPWpGaD
Cytarabine—POLD1—Removal of the Flap Intermediate from the C-strand—PCNA—focal segmental glomerulosclerosis	0.00486	0.0319	CbGpPWpGaD
Cytarabine—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.00423	0.0348	CbGeAlD
Cytarabine—POLD1—Processive synthesis on the C-strand of the telomere—PCNA—focal segmental glomerulosclerosis	0.0042	0.0276	CbGpPWpGaD
Cytarabine—SLC22A2—kidney—focal segmental glomerulosclerosis	0.00371	0.0306	CbGeAlD
Cytarabine—POLD1—Removal of the Flap Intermediate—PCNA—focal segmental glomerulosclerosis	0.00371	0.0244	CbGpPWpGaD
Cytarabine—POLD1—Leading Strand Synthesis—PCNA—focal segmental glomerulosclerosis	0.00371	0.0244	CbGpPWpGaD
Cytarabine—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.00362	0.0298	CbGeAlD
Cytarabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PCNA—focal segmental glomerulosclerosis	0.00351	0.0231	CbGpPWpGaD
Cytarabine—POLD1—Repair synthesis for gap-filling by DNA polymerase in TC-NER—PCNA—focal segmental glomerulosclerosis	0.00351	0.0231	CbGpPWpGaD
Cytarabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PCNA—focal segmental glomerulosclerosis	0.00351	0.0231	CbGpPWpGaD
Cytarabine—DCK—nephron tubule—focal segmental glomerulosclerosis	0.0035	0.0288	CbGeAlD
Cytarabine—POLE—Repair synthesis for gap-filling by DNA polymerase in TC-NER—PCNA—focal segmental glomerulosclerosis	0.00339	0.0223	CbGpPWpGaD
Cytarabine—POLD1—MMR—PCNA—focal segmental glomerulosclerosis	0.00333	0.0219	CbGpPWpGaD
Cytarabine—POLD1—Processive synthesis on the lagging strand—PCNA—focal segmental glomerulosclerosis	0.00333	0.0219	CbGpPWpGaD
Cytarabine—Glucosamine—MMP9—focal segmental glomerulosclerosis	0.0033	1	CrCbGaD
Cytarabine—SLC29A1—kidney—focal segmental glomerulosclerosis	0.00322	0.0265	CbGeAlD
Cytarabine—POLD1—Gap-filling DNA repair synthesis and ligation in GG-NER—PCNA—focal segmental glomerulosclerosis	0.00318	0.0209	CbGpPWpGaD
Cytarabine—POLD1—Removal of DNA patch containing abasic residue—PCNA—focal segmental glomerulosclerosis	0.00318	0.0209	CbGpPWpGaD
Cytarabine—SLC29A1—cortex of kidney—focal segmental glomerulosclerosis	0.00314	0.0258	CbGeAlD
Cytarabine—POLE—Gap-filling DNA repair synthesis and ligation in GG-NER—PCNA—focal segmental glomerulosclerosis	0.00307	0.0201	CbGpPWpGaD
Cytarabine—DCK—cortex of kidney—focal segmental glomerulosclerosis	0.003	0.0247	CbGeAlD
Cytarabine—ABCC10—kidney—focal segmental glomerulosclerosis	0.00293	0.0241	CbGeAlD
Cytarabine—POLD1—Base Excision Repair—PCNA—focal segmental glomerulosclerosis	0.00291	0.0191	CbGpPWpGaD
Cytarabine—ABCC10—cortex of kidney—focal segmental glomerulosclerosis	0.00285	0.0235	CbGeAlD
Cytarabine—POLD1—Lagging Strand Synthesis—PCNA—focal segmental glomerulosclerosis	0.00268	0.0176	CbGpPWpGaD
Cytarabine—SLC22A1—kidney—focal segmental glomerulosclerosis	0.00262	0.0216	CbGeAlD
Cytarabine—POLA1—Removal of the Flap Intermediate—PCNA—focal segmental glomerulosclerosis	0.00255	0.0168	CbGpPWpGaD
Cytarabine—POLA1—Leading Strand Synthesis—PCNA—focal segmental glomerulosclerosis	0.00255	0.0168	CbGpPWpGaD
Cytarabine—POLD1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—focal segmental glomerulosclerosis	0.00249	0.0164	CbGpPWpGaD
Cytarabine—POLE—Telomere C-strand (Lagging Strand) Synthesis—PCNA—focal segmental glomerulosclerosis	0.00241	0.0158	CbGpPWpGaD
Cytarabine—POLA1—Processive synthesis on the lagging strand—PCNA—focal segmental glomerulosclerosis	0.00229	0.0151	CbGpPWpGaD
Cytarabine—POLA1—G1/S-Specific Transcription—PCNA—focal segmental glomerulosclerosis	0.00219	0.0144	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.0021	0.0138	CbGpPWpGaD
Cytarabine—POLD1—Extension of Telomeres—PCNA—focal segmental glomerulosclerosis	0.00207	0.0136	CbGpPWpGaD
Cytarabine—POLE—Extension of Telomeres—PCNA—focal segmental glomerulosclerosis	0.002	0.0131	CbGpPWpGaD
Cytarabine—POLD1—DNA strand elongation—PCNA—focal segmental glomerulosclerosis	0.00191	0.0126	CbGpPWpGaD
Cytarabine—POLA1—Lagging Strand Synthesis—PCNA—focal segmental glomerulosclerosis	0.00185	0.0121	CbGpPWpGaD
Cytarabine—POLD1—Global Genomic NER (GG-NER)—PCNA—focal segmental glomerulosclerosis	0.00182	0.012	CbGpPWpGaD
Cytarabine—POLB—DNA Repair—PCNA—focal segmental glomerulosclerosis	0.00182	0.012	CbGpPWpGaD
Cytarabine—POLE—Global Genomic NER (GG-NER)—PCNA—focal segmental glomerulosclerosis	0.00176	0.0116	CbGpPWpGaD
Cytarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—focal segmental glomerulosclerosis	0.00172	0.0113	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.00159	0.0104	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.00154	0.0101	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.00149	0.00977	CbGpPWpGaD
Cytarabine—POLD1—Transcription-coupled NER (TC-NER)—PCNA—focal segmental glomerulosclerosis	0.00146	0.00957	CbGpPWpGaD
Cytarabine—POLA1—Extension of Telomeres—PCNA—focal segmental glomerulosclerosis	0.00143	0.00936	CbGpPWpGaD
Cytarabine—POLE—Transcription-coupled NER (TC-NER)—PCNA—focal segmental glomerulosclerosis	0.00141	0.00925	CbGpPWpGaD
Cytarabine—POLD1—Nucleotide Excision Repair—PCNA—focal segmental glomerulosclerosis	0.00134	0.0088	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.00134	0.00879	CbGpPWpGaD
Cytarabine—POLA1—DNA strand elongation—PCNA—focal segmental glomerulosclerosis	0.00132	0.00865	CbGpPWpGaD
Cytarabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.00132	0.00865	CbGpPWpGaD
Cytarabine—POLE—Nucleotide Excision Repair—PCNA—focal segmental glomerulosclerosis	0.00129	0.0085	CbGpPWpGaD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—PCNA—focal segmental glomerulosclerosis	0.00129	0.00844	CbGpPWpGaD
Cytarabine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.0012	0.00985	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—TGFB1—focal segmental glomerulosclerosis	0.00109	0.00716	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.00106	0.00696	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—PCNA—focal segmental glomerulosclerosis	0.00101	0.00664	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000945	0.00621	CbGpPWpGaD
Cytarabine—POLD1—Telomere Maintenance—PCNA—focal segmental glomerulosclerosis	0.000939	0.00617	CbGpPWpGaD
Cytarabine—POLE—Telomere Maintenance—PCNA—focal segmental glomerulosclerosis	0.000907	0.00595	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	0.000831	0.00546	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	0.000809	0.00531	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—PCNA—focal segmental glomerulosclerosis	0.000795	0.00522	CbGpPWpGaD
Cytarabine—POLD1—Chromosome Maintenance—PCNA—focal segmental glomerulosclerosis	0.000782	0.00514	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—PCNA—focal segmental glomerulosclerosis	0.000768	0.00504	CbGpPWpGaD
Cytarabine—POLE—Chromosome Maintenance—PCNA—focal segmental glomerulosclerosis	0.000755	0.00496	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.000746	0.0049	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.00072	0.00473	CbGpPWpGaD
Cytarabine—POLD1—DNA Repair—PCNA—focal segmental glomerulosclerosis	0.000698	0.00458	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—PCNA—focal segmental glomerulosclerosis	0.000694	0.00456	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—PCNA—focal segmental glomerulosclerosis	0.000674	0.00443	CbGpPWpGaD
Cytarabine—POLD1—S Phase—PCNA—focal segmental glomerulosclerosis	0.000652	0.00428	CbGpPWpGaD
Cytarabine—POLA1—Telomere Maintenance—PCNA—focal segmental glomerulosclerosis	0.000646	0.00424	CbGpPWpGaD
Cytarabine—POLE—S Phase—PCNA—focal segmental glomerulosclerosis	0.00063	0.00414	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000624	0.0041	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	0.000592	0.00389	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—PCNA—focal segmental glomerulosclerosis	0.000585	0.00384	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—PCNA—focal segmental glomerulosclerosis	0.000547	0.00359	CbGpPWpGaD
Cytarabine—POLA1—Chromosome Maintenance—PCNA—focal segmental glomerulosclerosis	0.000538	0.00353	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.000513	0.00337	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—PCNA—focal segmental glomerulosclerosis	0.000494	0.00325	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000482	0.00317	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000461	0.00303	CbGpPWpGaD
Cytarabine—POLA1—S Phase—PCNA—focal segmental glomerulosclerosis	0.000449	0.00295	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000439	0.00288	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—PCNA—focal segmental glomerulosclerosis	0.000417	0.00274	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000406	0.00267	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000374	0.00246	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000348	0.00229	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000316	0.00207	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000283	0.00186	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—LPL—focal segmental glomerulosclerosis	0.000281	0.00185	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000265	0.00174	CbGpPWpGaD
Cytarabine—CDA—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000242	0.00159	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AGT—focal segmental glomerulosclerosis	0.000241	0.00158	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000233	0.00153	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	0.000222	0.00146	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000215	0.00141	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	0.000214	0.00141	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000213	0.0014	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000198	0.0013	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000197	0.00129	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000192	0.00126	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ALB—focal segmental glomerulosclerosis	0.000185	0.00121	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000181	0.00119	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—LPL—focal segmental glomerulosclerosis	0.000162	0.00106	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	0.000153	0.001	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00015	0.000987	CbGpPWpGaD
Cytarabine—CDA—Metabolism—LPL—focal segmental glomerulosclerosis	0.000148	0.000971	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000144	0.000944	CbGpPWpGaD
Cytarabine—DCK—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000141	0.000928	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000141	0.000926	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AGT—focal segmental glomerulosclerosis	0.000138	0.000908	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000137	0.000897	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000132	0.000869	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AGT—focal segmental glomerulosclerosis	0.000127	0.000831	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000124	0.000817	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000122	0.000801	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000116	0.000762	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000115	0.000753	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000108	0.00071	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ALB—focal segmental glomerulosclerosis	0.000106	0.000697	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ALB—focal segmental glomerulosclerosis	9.71e-05	0.000638	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	9.42e-05	0.000619	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—LPL—focal segmental glomerulosclerosis	9.17e-05	0.000602	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	8.78e-05	0.000577	CbGpPWpGaD
Cytarabine—DCK—Metabolism—LPL—focal segmental glomerulosclerosis	8.62e-05	0.000566	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AGT—focal segmental glomerulosclerosis	7.85e-05	0.000515	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AGT—focal segmental glomerulosclerosis	7.38e-05	0.000485	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ALB—focal segmental glomerulosclerosis	6.02e-05	0.000395	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ALB—focal segmental glomerulosclerosis	5.66e-05	0.000372	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—LIPC—focal segmental glomerulosclerosis	5.6e-05	0.000368	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.22e-05	0.000343	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.93e-05	0.000324	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.79e-05	0.000314	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.59e-05	0.000302	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.54e-05	0.000298	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.46e-05	0.000293	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.23e-05	0.000278	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—LPL—focal segmental glomerulosclerosis	3.42e-05	0.000224	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	3.18e-05	0.000209	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.92e-05	0.000192	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	2.72e-05	0.000179	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ALB—focal segmental glomerulosclerosis	2.24e-05	0.000147	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	2.09e-05	0.000137	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.88e-05	0.000124	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.66e-05	0.000109	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.53e-05	0.0001	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.15e-05	7.55e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	9.83e-06	6.46e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	7.55e-06	4.96e-05	CbGpPWpGaD
